Results for tag: "Comtan"

The Comtan market is a segment of the Central Nervous System (CNS) drugs market. It is composed of drugs used to treat Parkinson's disease, a neurological disorder that affects movement. Comtan is a brand name for entacapone, a drug used to treat the symptoms of Parkinson's disease. It works by blocking the breakdown of dopamine, a neurotransmitter that helps control movement. Comtan is usually used in combination with other drugs, such as levodopa, to treat the symptoms of Parkinson's disease. The Comtan market is highly competitive, with many companies offering similar products. Some of the major players in the market include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Other companies in the market include Merck, GlaxoSmithKline, and Pfizer. Show Less Read more